The Chega de Fome Weight Loss Program, created by Dr. Laura Uchôa and offered at Diverse Care Now, combines medical weight-loss supervision, GLP-1 medications, and evidence-based lifestyle strategies to help patients achieve safe, sustainable fat loss.

This page brings expert guidance on: how GLP-1 medications (Semaglutide, Tirzepatide) improve appetite control, metabolism, and long-term weight stability; nutrition habits that support steady weight loss; daily movement strategies that boost energy and fat-burning; mindset and behavioral tools that make results last.

If you’re looking for a science-based weight-loss program with medical support, metabolic tracking, and predictable progress, this blog is your trusted resource.